Related Experiment Video
Updated: Apr 13, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses
Delin Chen1, Jing Shan, Wei-Guo Zhu
1Institute for Cancer Genetics, and Department of Pathology and Cell Biology College of Physicians & Surgeons, Columbia University, 1130 St Nicholas Avenue, New York, New York 10032, USA.
Abstract:
The tumour suppressor ARF is specifically required for p53 activation under oncogenic stress. Recent studies showed that p53 activation mediated by ARF, but not that induced by DNA damage, acts as a major protection against tumorigenesis in vivo under certain biological settings, suggesting that the ARF-p53 axis has more fundamental functions in tumour suppression than originally thought. Because ARF is a very stable protein in most human cell lines, it has been widely assumed that ARF induction is mediated mainly at the transcriptional level and that activation of the ARF-p53 pathway by oncogenes is a much slower and largely irreversible process by comparison with p53 activation after DNA damage. Here we report that ARF is very unstable in normal human cells but that its degradation is inhibited in cancerous cells. Through biochemical purification, we identified a specific ubiquitin ligase for ARF and named it ULF. ULF interacts with ARF both in vitro and in vivo and promotes the lysine-independent ubiquitylation and degradation of ARF. ULF knockdown stabilizes ARF in normal human cells, triggering ARF-dependent, p53-mediated growth arrest. Moreover, nucleophosmin (NPM) and c-Myc, both of which are commonly overexpressed in cancer cells, are capable of abrogating ULF-mediated ARF ubiquitylation through distinct mechanisms, and thereby promote ARF stabilization in cancer cells. These findings reveal the dynamic feature of the ARF-p53 pathway and suggest that transcription-independent mechanisms are critically involved in ARF regulation during responses to oncogenic stress.
Insights
Tumor suppressor ARF is unstable in normal cells but stabilized in cancer. A newly identified ubiquitin ligase, ULF, targets ARF for degradation, revealing a dynamic ARF-p53 pathway critical for tumor suppression.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cellular Regulation
Background:
- The ARF-p53 pathway is crucial for tumor suppression, particularly under oncogenic stress.
- Previous assumptions suggested ARF stability and slow transcriptional induction, contrasting with faster DNA damage-induced p53 activation.
- The ARF-p53 axis's role in tumor suppression is more fundamental than previously understood.
Purpose of the Study:
- To investigate the regulation of ARF stability and its role in the ARF-p53 pathway.
- To identify factors controlling ARF degradation and stabilization in normal and cancerous cells.
- To elucidate transcription-independent mechanisms in ARF regulation.
Main Methods:
- Biochemical purification to identify ARF-interacting proteins.
- In vitro and in vivo interaction studies between ARF and identified ligase.
- Ubiquitylation and degradation assays.
- Knockdown studies of the identified ubiquitin ligase.
- Analysis of ARF stabilization in cancer cells with overexpressed NPM and c-Myc.
Main Results:
- ARF is unstable in normal human cells but stabilized in cancerous cells.
- A specific ubiquitin ligase, ULF, was identified that targets ARF for ubiquitylation and degradation.
- ULF knockdown stabilizes ARF in normal cells, leading to p53-mediated growth arrest.
- Overexpressed NPM and c-Myc abrogate ULF-mediated ARF ubiquitylation, promoting ARF stabilization in cancer.
Conclusions:
- ARF regulation is dynamic and involves rapid degradation in normal cells, which is impaired in cancer.
- The ubiquitin ligase ULF is a key regulator of ARF stability.
- Transcription-independent mechanisms, influenced by NPM and c-Myc, are critical for ARF regulation in oncogenic stress response.
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Regulation of the Unfolded Protein Response
DNA Damage Can Stall the Cell Cycle

